Cardiovascular characterisation of UL-FS 49,1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylimino]propyl]-2H-3-benzazepin- 2-on hydrochloride, a new “specific bradycardic agent”

This publication has 11 references indexed in Scilit:

• Comparison of the bradycardic effects of alinidine (St 567), AQ-A 39 and verapamil on guinea-pig sinoatrial node superfused with different Ca2+ and NaCl solutions
  European Journal of Pharmacology, 1983
• Drugs with a class III antiarrhythmic action
  Pharmacology & Therapeutics, 1982
• Calcium channel block and recovery from block in mammalian ventricular muscle treated with organic channel inhibitors
  Pflügers Archiv - European Journal of Physiology, 1982
• Electrophysiological effects of sotalol--just another beta blocker?
  Heart, 1982
• Influence of heart rate and inhibition of autonomic tone on the QT interval.
  Circulation, 1982
• The electrophysiological basis of the bradycardic action of AQA 39 on the sinoatrial node
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1981
• AQ-A 39 (5,6-dimethoxy-2-[3[[α-(3,4-dimethoxy)-phenyl-ethyl]methylamino]propyl]phtalimidine), a specific bradycardic agent with direct action on the heart
  European Journal of Pharmacology, 1981
• Cardiovascular actions of N-allyl-clonidine (ST 567), a substance with specific bradycardic action
  European Journal of Pharmacology, 1979
• N-Allyl-derivative of clonidine, a substance with specific bradycardic action at a cardiac site
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1979
• A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474
  British Journal of Pharmacology, 1970